publication date: Dec. 21, 2010

In this issue: 

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC;

Unclear Whether Insurance Will Cover AACR Losses;

FDA, ASCO Meet to Review Drug Approval Endpoints;

Chemical Society Designates Taxol, Camptothecin Discoveries Historic;

Funding Opportunities (8-page issue).

Download (PDF 199KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.